Stability of Employment Status Among Patients with Highly Active Relapsing Multiple Sclerosis During the 2-year CLARIFY-MS Study

被引：0
|
作者：
Selmaj, K. [1 ]
Langdon, D. [2 ]
Brochet, B. [3 ]
Havrdova, E. K. [4 ]
Lechner-Scott, J. [5 ,6 ]
Montalban, X. [7 ]
Patti, F. [8 ,9 ]
Piehl, F. [10 ]
Solari, A. [11 ]
Alexandri, N. [12 ]
Nolting, A. [12 ]
Lehn, A. [12 ]
Smyk, A. [12 ]
机构：
[1] Ctr Neurol, Lodz, Poland
[2] Royal Holloway Univ London, Dept Psychol, Egham, Surrey, England
[3] Univ Bordeaux, INSERM U 1215, Bordeaux, France
[4] Charles Univ Prague, Med Fac 1, Prague, Czech Republic
[5] Univ Newcastle, Newcastle, NSW, Australia
[6] John Hunter Hosp, Div Neurol, Newcastle, NSW, Australia
[7] Univ Hosp Vall Hebron, Dept Neurol Neuroimmunol, Ctr Multiple Sclerosis Catalonia Cemcat, Barcelona, Spain
[8] Univ Catania, GF Ingrassia, Dept Med & Surg Sci & Adv Technol, Catania, Italy
[9] Univ Catania, Azienda Osped Univ Policlin G Rodolico San Marco, Catania, Italy
[10] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[11] Fdn IRCCS Ist Neurol Carlo Bes, Unit Neuroepidemiol, Milan, Italy
[12] Healthcare Business Merck KGaA, Darmstadt, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P089
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [1] Stabilization of Cognitive Function in Patients With Highly Active Relapsing Multiple Sclerosis Treated With Cladribine Tablets During the 2-Year CLARIFY-MS study
    Langdon, D.
    Brochet, B.
    Havrdova, E. K.
    Lechner-Scott, J.
    Montalban, X.
    Patti, F.
    Piehl, F.
    Selmaj, K.
    Solari, A.
    Alexandri, N.
    Nolting, A.
    Lehn, A.
    Smyk, A.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 60 - 61
  • [2] Improvements in quality of life of people with relapsing multiple sclerosis treated with cladribine tablets during the 2-year CLARIFY-MS study: a plain language summary
    Brochet, Bruno
    Solari, Alessandra
    Lechner-Scott, Jeannette
    Piehl, Fredrik
    Langdon, Dawn
    Hupperts, Raymond
    Selmaj, Krzysztof
    Patti, Francesco
    Brieva, Luis
    Maidal, Eva Maria
    Alexandri, Nektaria
    Smyk, Andrzej
    Nolting, Axel
    Montalban, Xavier
    Havrdova, Eva Kubala
    CLARIFY-MS Investigators
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2024, 14 (06) : 193 - 201
  • [3] Treatment Satisfaction in Patients with Highly-active Relapsing Multiple Sclerosis Treated with Cladribine Tablets: CLARIFY-MS Study Interim Analysis
    Brochet, Bruno
    Hupperts, Raymond
    Langdon, Dawn
    Solari, Alessandra
    Piehl, Fredrik
    Lechner-Scott, Jeanette
    Montalban, Xavier
    Selmaj, Krzysztof
    Valis, Martin
    Havrdova, Eva
    Rejdak, Konrad
    Patti, Francesco
    Alexandri, Nektaria
    Nolting, Axel
    Keller, Birgit
    NEUROLOGY, 2021, 96 (15)
  • [4] Treatment satisfaction in patients with highly-active relapsing multiple sclerosis treated with cladribine tablets: clarify-ms study interim analysis
    Brochet, B.
    Hupperts, R. H. Raymond
    Langdon, D.
    Solari, A.
    Piehl, F.
    Lechner-Scott, J.
    Montalban, X.
    Selmaj, K.
    Valis, M.
    Rejdak, K.
    Havrdova, E. Kubala
    Patti, F.
    Alexandri, N.
    Nolting, A.
    Keller, B.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 623 - 623
  • [5] Improvements in quality of life over 2 years in patients treated with cladribine tablets for highly active relapsing multiple sclerosis: Final analysis of CLARIFY-MS
    Solari, A.
    Montalban, X.
    Lechner-Scott, J.
    Piehl, F.
    Brochet, B.
    Langdon, D.
    Hupperts, R.
    Selmaj, K.
    Havrdova, E. K.
    Patti, F.
    Brieva, L.
    Maida, E. M.
    Alexandri, N.
    Smyk, A.
    Nolting, A.
    Keller, B.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 203 - 204
  • [6] Improvements in QoL at 1 year in patients treated with cladribine tablets for highly active relapsing MS: an interim analysis of CLARIFY-MS
    Solari, A.
    Montalban, X.
    Lechner-Scott, J.
    Piehl, F.
    Brochet, B.
    Langdon, D.
    Hupperts, R.
    Selmaj, K.
    Havrdova, E. K.
    Patti, F.
    Brieva, L.
    Maida, E. M.
    Alexandri, N.
    Kamudoni, P.
    Nolting, A.
    Keller, B.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 284 - 285
  • [7] Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis
    Brochet, Bruno
    Hupperts, Raymond
    Langdon, Dawn
    Solari, Alessandra
    Piehl, Fredrik
    Lechner-Scott, Jeannette
    Montalban, Xavier
    Selmaj, Krzysztof
    Valis, Martin
    Rejdak, Konrad
    Havrdova, Eva K.
    Patti, Francesco
    Alexandri, Nektaria
    Nolting, Axel
    Keller, Birgit
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [8] Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study
    Brochet, Bruno
    Solari, Alessandra
    Lechner-Scott, Jeannette
    Piehl, Fredrik
    Langdon, Dawn
    Hupperts, Raymond
    Selmaj, Krzysztof
    Patti, Francesco
    Brieva, Luis
    Maida, Eva Maria
    Alexandri, Nektaria
    Smyk, Andrzej
    Nolting, Axel
    Keller, Birgit
    Montalban, Xavier
    Kubala Havrdova, Eva
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (14) : 1808 - 1818
  • [9] Time to Qualifying Relapse by Previous Disease Modifying Therapy Status in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets over 2 Years in the CLARIFY-MS Study
    Patti, Francesco
    Brochet, Bruno
    Havrdova, Eva Kubala
    Solari, Alessandra
    Hupperts, R. M. M.
    Langdon, Dawn
    Lechner-Scott, Jeannette
    Piehl, Fredrik
    Selmaj, Krzysztof
    Smyk, Andrzej
    Lehn, Annette
    Montalban, Xavier
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 747 - 748
  • [10] Cognitive functioning as a predictor of employment status in relapsing-remitting multiple sclerosis: a 2-year longitudinal study
    Dennis A.M. van Gorp
    Karin van der Hiele
    Marco A.P. Heerings
    Peter J. Jongen
    Jac J.L. van der Klink
    Michiel F. Reneman
    Edo P.J. Arnoldus
    Ernesto A.C. Beenakker
    Jeroen J.J. van Eijk
    Stephan T.F.M. Frequin
    Koen de Gans
    Elske Hoitsma
    Jop P. Mostert
    Wim I.M. Verhagen
    Désirée Zemel
    Leo H. Visser
    Huub A.M. Middelkoop
    Neurological Sciences, 2019, 40 : 2555 - 2564
12345